IL10 and breast cancer: For example, the cancer immunotherapy trial network (CITN) has considered a pilot clinical trial testing the combination of topical imiquimod and IL-10 blockade in breast cancer patients with chest wall metastasis (per communication with Dr. Martin Cheever, CITN director).